Clinical studies of livedoid vasculitis: (segmental hyalinizing vasculitis).
D000293:Adolescent; D000328:Adult; D000368:Aged; D001780:Blood Coagulation Tests; D001797:Blood Protein Electrophoresis; D002648:Child; D002908:Chronic Disease; D003165:Complement System Proteins / Q000032:analysis; D005260:Female; D005455:Fluorescent Antibody Technique; D005500:Follow-Up Studies; D006145:Guanethidine / Q000627:therapeutic use; D006801:Humans; D007105:Immune Complex Diseases / Q000150:complications; D007136:Immunoglobulins / Q000032:analysis; D007249:Inflammation / Q000188:drug therapy; D007871:Leg Ulcer / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy; D008180:Lupus Erythematosus, Systemic / Q000150:complications; D008297:Male; D008875:Middle Aged; D009539:Nicotinic Acids / Q000627:therapeutic use; D010523:Peripheral Nervous System Diseases / Q000150:complications; D010488:Polyarteritis Nodosa / Q000150:complications; D011725:Pyridines / Q000627:therapeutic use; D011928:Raynaud Disease / Q000150:complications; D012882:Skin Tests; D013424:Sulfanilamides / Q000031:analogs & derivatives / Q000627:therapeutic use; D014652:Vascular Diseases / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy
D007136:Immunoglobulins; D009539:Nicotinic Acids; D011725:Pyridines; D013424:Sulfanilamides; D003165:Complement System Proteins; D006145:Guanethidine